SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Teitelbaum SL 2000 Bone resorption by osteoclasts. Science 289:15041508.
  • 2
    Nagase H 1996 Matrix metalloproteinases. In: HooperNM (ed.) Zinc Metalloproteinases in Health and Disease. Taylor & Francis Ltd., London, UK, pp. 153204.
  • 3
    Woessner JF Jr 1998 The matrix metalloproteinase family. In: ParksWC, MechamRP (eds.) Matrix Metalloproteinases. Academic Press, San Diego, CA, USA, pp. 114.
  • 4
    Woessner JF, Nagase H 2000 Matrix Metalloproteinases and TIMPs, Oxford University Press, New York, NY, USA.
  • 5
    Edwards DR, Beaudry PP, Laing TD, Kowal V, Leco KJ, Leco PA, Lim MS 1996 The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obes 20(Suppl 3):S9S15.
  • 6
    Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP 1997 Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 7:111122.
  • 7
    Murate T, Hayakawa T 1999 Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): New aspects in hematopoiesis. Platelets 10:516.
  • 8
    Katunuma N 1997 Molecular mechanisms of bone collagen degradation in bone resorption. J Bone Miner Metab 15:18.
  • 9
    Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, Yamamura T 1997 Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272:81098112.
  • 10
    Delaissé JM, Eeckhout Y, Neff L, Francois-Gillet C, Henriet P, Su Y, Vaes G, Baron R 1993 (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 106:10711082.
  • 11
    Okamura T, Shimokawa H, Takagi Y, Ono H, Sasaki S 1993 Detection of collagenase mRNA in odontoclasts of bovine root-resorbing tissue by in situ hybridization. Calcif Tissue Int 52:325330.
  • 12
    Hill PA, Murphy G, Docherty AJP, Hembry RM, Millican TA, Reynolds JJ, Meikle MC 1994 The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107:30553064.
  • 13
    Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K 1994 High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:10911102.
  • 14
    Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y, Kumegawa M 1994 Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269:1500615009.
  • 15
    Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H, Seiki M 1995 Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: Implication for bone resorption. Lab Invest 72:311322.
  • 16
    Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH 1996 Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res 11:7278.
  • 17
    Sato T, Del Carmen Ovejero M, Hou P, Heegaad A-M, Kumegawa M, Foged NT, Delaissé J-M 1997 Identification of the membrane-type matrix metalloproteinase MTI-MMP in osteoclasts. J Cell Sci 110:589596.
  • 18
    Shimizu H, Sakamoto M, Sakamoto S 1990 Bone resorption by isolated osteoclasts in living versus devitalized bone: Differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases. J Bone Miner Res 5:411418.
  • 19
    Hill PA, Reynolds JJ, Meikle MC 1993 Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1177:7174.
  • 20
    Delaissé JM, Boyde A, Maconnachie E, Ali NN, Sear CHJ, Eeckhout Y, Vaes G, Jones SJ 1987 The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305313.
  • 21
    Everts V, Beertsen W, Schröder R 1988 Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int 43:172178.
  • 22
    Everts V, Delaissé JM, Korper W, Niehof A, Vaes G, Beertsen W 1992 Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinase. J Cell Physiol 150:221231.
  • 23
    Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC 1994 Inhibition of bone resorption by selective inactivators of cysteine proteases. J Cell Biochem 56:118130.
  • 24
    Hill PA, Docherty AJP, Bottomley KM, O'Connell JP, Morphy JR, Reynolds JJ, Meikle MC 1995 Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem J 308:167175.
  • 25
    Sato T, Foged NT, Delaissé J-M 1998 The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res 13:5966.
  • 26
    Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJP, Beertsen W 1999 Functional heterogeneity of osteoclasts: Matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 13:12191230.
  • 27
    Shibutani T, Yamashita K, Aoki T, Iwayama Y, Nishikawa T, Hayakawa T 1999 Tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) stimulate osteoclastic bone resorption. J Bone Miner Metab 17:245251.
  • 28
    Kodama S, Kishi J, Obata K, Iwata K, Hayakawa T 1987 Monoclonal antibodies to bovine collagenase inhibitor. Coll Relat Res 7:341350.
  • 29
    Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T 1993 A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 220:3145.
  • 30
    Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T 1990 Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127:103108.
  • 31
    Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A 1994 Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 107:23732379.
  • 32
    Naito K, Kanbayashi N, Nakajima S, Murai T, Arakawa K, Nishimura S, Okuyama A 1994 Inhibition of growth of human tumor cells in nude mice by a metalloproteinase inhibitor. Int J Cancer 58:730735.
  • 33
    Tamaki K, Tanzawa K, Kurihara S, Oikawa T, Monma S, Shimada K, Sugimura Y 1995 Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins. Chem Pharm Bull (Tokyo) 43::18831893.
  • 34
    Kakudo S, Miyazawa K, Kameda T, Mano H, Mori Y, Yuasa T, Nakamaru Y, Shiokawa M, Nagahira K, Tokunaga S, Hakeda Y, Kumegawa M 1996 Isolation of highly enriched rabbit osteoclasts from collagen gels: A new assay system for bone-resorbing activity of mature osteoclasts. J Bone Miner Metab 14:129136.
  • 35
    Takada Y, Kusuda M, Hiura K, Sato T, Mochizuki H, Nagao Y, Tomura M, Yahiro M, Hakeda Y, Kawashima H, Kumegawa M 1992 A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Miner 17:347359.
  • 36
    Tezuka K, Sato T, Kamioka H, Nijweide PJ, Tanaka K, Ma-Tsuo T, Ohta M, Kurihara N, Hakeda Y, Kumegawa M 1992 Identification of osteopontin in isolated rabbit osteoclasts. Biochem Biophys Res Commun 186:911917.
  • 37
    Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156159.
  • 38
    Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K 1992 Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. FEBS Lett 298:2932.
  • 39
    Nemeth JA, Rafe A, Steiner M, Goolsby CL 1996 TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin. Exp Cell Res 224:110115.
  • 40
    Yamashita K, Suzuki M, Iwata H, Koike T, Hamaguchi M, Shinagawa A, Noguchi T, Hayakawa T 1996 Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). FEBS Lett 396:103107.
  • 41
    Kikuchi K, Kadono T, Furue M, Tamaki K 1997 Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 108:281284.
  • 42
    Murate T, Yamashita K, Isogai C, Suzuki H, Ichihara M, Hatano S, Nakahara Y, Kinoshita T, Nagasaka T, Yoshida S, Komatsu N, Miura Y, Hotta T, Fujimoto N, Saito H, Ha-Yakawa T 1997 The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: Possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis. Br J Haematol 99:181189.
  • 43
    Saika S, Kawashima Y, Okada Y, Tanaka S, Yamanaka O, Ohnishi Y, Ooshima A 1998 Recombinant TIMP-1 and −2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ. Curr Eye Res 17:4752.
  • 44
    Luparello C, Avanzato G, Carella C, Pucci-Minafra I 1999 Tissue inhibitor of metalloproteinase (TIMP)-1 and proliferative behaviour of clonal breast cancer cells. Breast Cancer Res Treat 54:235244.
  • 45
    Naito K, Nakajima S, Kanbayashi N, Okuyama A, Goto M 1993 Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl)-seryl-L-valine]. Agents Actions 39:182186.
  • 46
    Fantl WJ, Johnson DE, Williams LT 1993 Signalling by receptor tyrosine kinases. Annu Rev Biochem 62:453481.
  • 47
    Cobb MH, Goldsmith EJ 1995 How MAP kinases are regulated. J Biol Chem 270:1484314846.
  • 48
    Seger R, Krebs EG 1995 The MAPK signaling cascade. FASEB J 9:726735.
  • 49
    Chikazu D, Hakeda Y, Ogata N, Nemoto K, Itabashi A, Takato T, Kumegawa M, Nakamura K, Kawaguchi H 2000 Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J Biol Chem 275:3144431450.
  • 50
    Insogna KL, Sahni M, Grey AB, Tanaka S, Horne WC, Neff L, Mitnick M, Levy JB, Baron R 1997 Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100:24762485.
  • 51
    Katagiri M, Hakeda Y, Chikazu D, Ogasawara T, Takato T, Kumegawa M, Nakamura K, Kawaguchi H 2001 Mechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts. J Biol Chem 276:73767382.
  • 52
    Nakagawa M, Kaneda T, Arakawa T, Morita S, Yamada T, Hanada K, Kumegawa M, Hakeda Y 2000 Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone-resorption and survival of mature osteoclasts. FEBS Lett 473:161164.
  • 53
    Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S 2000 Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J Cell Biol 148:333342.
  • 54
    Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR 1992 Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:16221627.
  • 55
    Roodman GD 1999 Cell biology of the osteoclast. Exp Hematol 27:12291241.
  • 56
    Rifas L, Halstead LR, Peck WA, Avioli LV, Welgus HG 1989 Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J Clin Invest 84:686694.
  • 57
    Overall CM, Wrana JL, Sodek J 1989 Transforming growth factor-β regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Connect Tissue Res 20:289294.
  • 58
    Johansen JS, Williamson MK, Rice JS, Price PA 1992 Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res 7:501512.
  • 59
    Rifas L, Fausto A, Scott MJ, Avioli LV, Welgus HG 1994 Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: Differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134:213221.
  • 60
    Meikle MC, Bord S, Hembry RM, Reynolds JJ 1994 Rabbit calvarial osteoblasts in culture constitutively synthesize progelatinase-A, and TIMP-1 and TIMP-2. Biochim Biophys Acta 1224:99102.
  • 61
    Meikle MC, Bord S, Hembry RM, Reynolds JJ 1995 The synthesis of collagenase, gelatinase-A (72 kDa) and -B (95 kDa), and TIMP-1 and −2 by human osteoblasts from normal and arthritic bone. Bone 17:255260.
  • 62
    Breckon JJW, Papaioannou S, Kon LWM, Tumber A, Hembry RM, Murphy G, Reynolds JJ, Meikle MC 1999 Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J Bone Miner Res 14:18801890.
  • 63
    De Bart ACW, Quax PHA, Lowik CWGM, Verheijen JH 1995 Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. J Bone Miner Res 10:13741384.
  • 64
    Ohishi K, Fujita N, Morinaga Y, Tsuruo T 1995 H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption. Clin Exp Metastasis 13:287295.
  • 65
    Varghese S, Ramsby ML, Jeffrey JJ, Canalis E 1995 Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136:21562162.
  • 66
    Varghese S, Yu K, Canalis E 1999 Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts. Am J Physiol 276:E465E471.
  • 67
    Varghese S, Canalis E 1997 Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology 138:10351040.
  • 68
    Avalos BR, Kaufman SE, Tomonaga M, Williams RE, Golde DW, Gasson JC 1988 K562 cells produce and respond to human erythroid-potentiating activity. Blood 71:17201725.
  • 69
    Bertaux B, Hornebeck W, Eisen AZ, Dubertret L 1991 Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679685.
  • 70
    Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y 1996 Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56:27072710.
  • 71
    Zucker S, Drews M, Conner C, Foda HD, Declerck YA, Langley KE, Bahou WF, Docherty AJP, Cao J 1998 Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273:12161222.
  • 72
    Hakeda Y, Kobayashi Y, Yamaguchi K, Yasuda H, Tsuda E, Higashio K, Miyata T, Kumegawa M 1998 Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. Biochem Biophys Res Commun 251:796801.
  • 73
    Guedez L, Courtemanch L, Stetler-Stevenson M 1998 Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood 92:13421349.
  • 74
    Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M 1998 In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinase-1. J Clin Invest 102:20022010.
  • 75
    Valente P, Fassina G, Melchiori A, Masiello L, Cilli M, Vacca A, Onisto M, Santi L, Stetler-Stevenson WG, Albini A 1998 TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 75:246253.